Patents by Inventor Masao Hirakata

Masao Hirakata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compound
    Patent number: 10676461
    Abstract: The present invention relates to N-((3S,4R)-1-((8-chloroquinoxalin-6-yl)carbonyl)-3-(4-fluorophenyl)piperidin-4-yl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide, which is a compound that can be useful for the treatment or prevention of SPT-related diseases including congenital diseases associated with the storage of sphingolipids, such as cancer and Niemann-Pick disease, or a salt thereof.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: June 9, 2020
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Katsunori Nagai, Takuto Kojima, Shinichi Imamura, Masao Hirakata
  • HETEROCYCLIC COMPOUND
    Publication number: 20190263784
    Abstract: The present invention relates to N-((3S,4R)-1-((8-chloroquinoxalin-6-yl)carbonyl)-3-(4-fluorophenyl)piperidin-4-yl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide, which is a compound that can be useful for the treatment or prevention of SPT-related diseases including congenital diseases associated with the storage of sphingolipids, such as cancer and Niemann-Pick disease, or a salt thereof.
    Type: Application
    Filed: October 17, 2017
    Publication date: August 29, 2019
    Inventors: Katsunori NAGAI, Takuto KOJIMA, Shinichi IMAMURA, Masao HIRAKATA
  • Abc expression promoters
    Publication number: 20040077689
    Abstract: The ABCA1 mRNA expression-promoting agent, LXR&agr; mRNA expression-promoting agent, ABCG1 mRNA expression-promoting agent, cholesterol efflux-promoting agent, cholesteryl ester accumulation-inhibiting agent, ACAT-1 mRNA expression-inhibiting agent and CEH mRNA expression-promoting agent of the present invention are excellent in the ability to control cholesterol distribution in the body and have low toxicity.
    Type: Application
    Filed: October 16, 2003
    Publication date: April 22, 2004
    Inventors: Yasuo Sugiyama, Hiromatsu Fuse, Masao Hirakata, Ryuichi Tozawa
  • Fibrinogen-lowering agents
    Publication number: 20030187038
    Abstract: We offer a fibrinogen-lowering agent comprising a compound having an angiotensin II antagonistic activity, a prodrug thereof, or a salt thereof. Because of having an excellent effect of lowering fibrinogen, the above fibrinogen-lowering agent is useful as a prophylactic or therapeutic agent for various diseases caused by hyperfibrionogenemia, etc.
    Type: Application
    Filed: February 14, 2003
    Publication date: October 2, 2003
    Inventors: Yoshimi Imura, Masao Hirakata